These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Insulin secretory and antidiabetic actions of Heritiera fomes bark together with isolation of active phytomolecules. Ansari P; Flatt PR; Harriott P; Abdel-Wahab YHA PLoS One; 2022; 17(3):e0264632. PubMed ID: 35239729 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Antidiabetic and Insulin Releasing Effects of Ansari P; Flatt PR; Harriott P; Abdel-Wahab YHA Plants (Basel); 2020 Oct; 9(10):. PubMed ID: 33053901 [No Abstract] [Full Text] [Related]
8. Identification of Multiple Pancreatic and Extra-Pancreatic Pathways Underlying the Glucose-Lowering Actions of Ansari P; Flatt PR; Harriott P; Hannan JMA; Abdel-Wahab YHA Plants (Basel); 2021 Jun; 10(6):. PubMed ID: 34208010 [No Abstract] [Full Text] [Related]
9. Anti-hyperglycaemic activity of H. rosa-sinensis leaves is partly mediated by inhibition of carbohydrate digestion and absorption, and enhancement of insulin secretion. Ansari P; Azam S; Hannan JMA; Flatt PR; Abdel Wahab YHA J Ethnopharmacol; 2020 May; 253():112647. PubMed ID: 32035878 [TBL] [Abstract][Full Text] [Related]
10. Insulinotropic and antidiabetic properties of Eucalyptus citriodora leaves and isolation of bioactive phytomolecules. Ansari P; Flatt PR; Harriott P; Abdel-Wahab YHA J Pharm Pharmacol; 2021 Jul; 73(8):1049-1061. PubMed ID: 33755147 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antihyperglycemic activity of the ethanol extract of Heritiera fomes bark and characterization of pharmacologically active phytomolecules. Ansari P; Azam S; Seidel V; Abdel-Wahab YHA J Pharm Pharmacol; 2022 Mar; ():. PubMed ID: 35230449 [TBL] [Abstract][Full Text] [Related]
12. A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice. Bhat VK; Kerr BD; Vasu S; Flatt PR; Gault VA Diabetologia; 2013 Jun; 56(6):1417-24. PubMed ID: 23503814 [TBL] [Abstract][Full Text] [Related]
13. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice. Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366 [TBL] [Abstract][Full Text] [Related]
16. Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels. Willard JR; Barrow BM; Zraika S Diabetologia; 2017 Apr; 60(4):701-708. PubMed ID: 27933334 [TBL] [Abstract][Full Text] [Related]
17. Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro. Kasabri V; Flatt PR; Abdel-Wahab YH Br J Nutr; 2010 Jan; 103(2):212-7. PubMed ID: 19723351 [TBL] [Abstract][Full Text] [Related]
18. Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion. McKillop AM; Ng MT; Abdel-Wahab YH; Flatt PR Diabetes Obes Metab; 2014 Oct; 16(10):937-46. PubMed ID: 24702738 [TBL] [Abstract][Full Text] [Related]
19. Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. Green BD; Gault VA; Mooney MH; Irwin N; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP J Mol Endocrinol; 2003 Dec; 31(3):529-40. PubMed ID: 14664713 [TBL] [Abstract][Full Text] [Related]
20. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1. Duffy NA; Green BD; Irwin N; Gault VA; McKillop AM; O'Harte FP; Flatt PR Eur J Pharmacol; 2007 Jul; 568(1-3):278-86. PubMed ID: 17573070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]